ArticleInvestigational new drugs2016

Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.

Joleen M Hubbard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.